Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 1
2010 1
2014 2
2015 1
2017 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Matsubayashi H, et al. World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. World J Gastroenterol. 2017. PMID: 28246467 Free PMC article. Review.
Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for 4%-10% of PC. Several genetic syndromes, including Peutz-Jeghers syndrome, hereditary pancreatitis, hereditary brea …
Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for …
Uterine serous carcinoma: key advances and novel treatment approaches.
Ferriss JS, Erickson BK, Shih IM, Fader AN. Ferriss JS, et al. Int J Gynecol Cancer. 2021 Aug;31(8):1165-1174. doi: 10.1136/ijgc-2021-002753. Epub 2021 Jul 1. Int J Gynecol Cancer. 2021. PMID: 34210768 Review.
The incidence and mortality rates from endometrial cancer continue to increase worldwide, while rates in most other cancers have either plateaued or declined considerably. ...Clinical risk factors for uterine serous carcinoma include advancing age, a history of breast …
The incidence and mortality rates from endometrial cancer continue to increase worldwide, while rates in most other cancers have eith …
Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M, Solomon S. Marshall M, et al. Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7. Plast Surg Nurs. 2007. PMID: 17901820 Review.
Of these cases, 84% of hereditary breast cancer and more than 90% of hereditary ovarian cancer are caused by mutations in the BRCA1 or BRCA2 genes. Family histories of cancer are an essential tool in identifying features of and ind …
Of these cases, 84% of hereditary breast cancer and more than 90% of hereditary ovarian cancer are …
Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
Hinshaw JC, Zhao LP, Brimm JE, Payne TH, Hisama FM. Hinshaw JC, et al. J Genet Couns. 2021 Dec;30(6):1591-1597. doi: 10.1002/jgc4.1425. Epub 2021 Apr 21. J Genet Couns. 2021. PMID: 33881185
Our work evaluates the contributions of a genetics clinic visit in assessing patients' risk of hereditary cancers and in meeting National Cancer Comprehensive Network (NCCN) criteria for genetic testing. ...We searched for all personal or family cancer histor …
Our work evaluates the contributions of a genetics clinic visit in assessing patients' risk of hereditary cancers and in meeting Nati …
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM, Powell CB, Chen LM, Richardson DL; SGO Clinical Practice Committee. Lancaster JM, et al. Gynecol Oncol. 2015 Jan;136(1):3-7. doi: 10.1016/j.ygyno.2014.09.009. Epub 2014 Sep 17. Gynecol Oncol. 2015. PMID: 25238946
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast & Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and up to a 46% lifetime ris …
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast &am …
Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain).
Cuevas-Cuerda D, Salas-Trejo D. Cuevas-Cuerda D, et al. Fam Cancer. 2014 Jun;13(2):301-9. doi: 10.1007/s10689-013-9693-0. Fam Cancer. 2014. PMID: 24242329
Descriptive analysis of organisational and effectiveness indicators from the start in 2005 until December 2010: correct referral of patients according to the area from where they were referred (primary or hospital-based care) and syndrome; families identified as hav …
Descriptive analysis of organisational and effectiveness indicators from the start in 2005 until December 2010: correct referral of patients …
Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
Brandt A, Lorenzo Bermejo J, Sundquist J, Hemminki K. Brandt A, et al. Breast Cancer Res Treat. 2010 May;121(1):133-41. doi: 10.1007/s10549-009-0486-y. Epub 2009 Jul 30. Breast Cancer Res Treat. 2010. PMID: 19641988
Family history is a strong predictor of hereditary breast cancer, particularly when it includes cases of early onset or bilateral breast cancers and multiple cases of breast or ovarian cancers. ...The women of the nation-wide Swedish Fami …
Family history is a strong predictor of hereditary breast cancer, particularly when it includes cases of early onset or …
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee. Lancaster JM, et al. Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031. Gynecol Oncol. 2007. PMID: 17950381
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast/Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and up to a 46% lifetime risk o …
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast/ …